Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from The Kiplinger Letter

Biden Has One Last Obamacare Policy To Roll Out: The Kiplinger Letter

This final Obamacare policy would require states to synchronize open enrollment if they operate their own Obamacare exchanges.

Kiplinger

Consumers Feel Glum About the Economy: The Kiplinger Letter

Surveys show that consumers feel glum and wary about what comes next, despite their uptick in spending.

Kiplinger

Delinquent CRE Loans Are on the Rise: The Kiplinger Letter

Banks are expanding their efforts to restructure CRE loans to avoid losses from the commercial real estate sector.

Kiplinger

From analysis to the latest developments in health,
read the most diverse news in one place.

Agricultural Drone Progress at Risk from Regulators: The Kiplinger Letter

U.S. agricultural drone progress is losing ground to countries with fewer regulatory restraints — notably China.

Kiplinger

Boeing Sees a Resurgence in Sales: The Kiplinger Letter

Boeing has benefited from a surge of new orders in October, with November expected to be even better.

Kiplinger

Yuan Growing in Use in Cross-Border Trade: The Kiplinger Letter

Transactions settled in yuan, between China and the rest of the world, have grown by 24% in the first three quarters of this year alone.

Kiplinger

Senate Control Will Likely Come Down to Just Two States: The Kiplinger Letter

Montana and Ohio may hold the key to control in the Senate as the Democrats angle for control.

Kiplinger

Read news from The Economist, FT, and more,
with one subscription

Videoconferencing Platforms Get an AI Boost: The Kiplinger Letter

Emerging AI tools give videoconferencing platforms like Microsoft Teams and Zoom the ability to add a virtual assistant to every online meeting.

Kiplinger

Semiconductor Sales Will Bounce Back Next Year: The Kiplinger Letter

Global semiconductor sales will rebound in 2024 driven by a frenzy of innovation.

Kiplinger

The GOP Field of Presidential Candidates Is Shrinking Fast: The Kiplinger Letter

Only five GOP candidates remain in the fight for the White House, as those struggling in the polls put their campaigns on hold.

Kiplinger

U.S. Natural Gas Prices Are Down, Supplies Are Up: The Kiplinger Letter

U.S. natural gas prices are down from last year, while production and exports keep hitting new highs.

Kiplinger

Tesla's Cybertruck Unlikely to Win Over Traditional Buyers: The Kiplinger Letter

Despite the buzz over Tesla's foray into the electric truck market, its Cybertruck suffers from shortcomings that will put off many buyers.

Kiplinger

Move Over Biden, Congress' Approval Rating is Just 13%: The Kiplinger Letter

According to a recent Gallup poll, Congress’ approval rating is the lowest since 2017.

Kiplinger

As Mortgage Rates Rise, Renting Is Now Cheaper Than Buying for Many: The Kiplinger Letter

A jump in mortgage rates has caused housing affordability to slump and priced many first-time home buyers out of the market.

Kiplinger

Get all your
news in one place.

100’s of premium titles.
One news app.

Kiplinger

As Cable Companies Move into Mobile, Customers Benefit: The Kiplinger Letter

The new cable bundle — home internet and mobile — is gaining steam. And the competition means good news for consumers.

Kiplinger

Buy Now, Pay Later (BNPL) Sector Faces Financial and Regulatory Challenges: The Kiplinger Letter

BNPL companies are facing the challenges of high costs, tightening financial conditions and regulatory scrutiny.

Kiplinger

Speaker Mike Johnson’s Honeymoon is Over: The Kiplinger Letter

House Republicans remain divided on key initiatives.

Kiplinger

New Voice Cloning Scam Has Regulators Scrambling for Solutions: The Kiplinger Letter

As fraudsters add voice cloning technology to their arsenal of deception, regulators are playing catch-up.

Get all your
news in one place.

100’s of premium titles.
One news app.

Kiplinger

FDA Approves Zepbound, the Latest Weight-Loss Drug: The Kiplinger Letter

Eli Lily’s Zepbound will undercut its rivals’ pricing but still costs over $1,000 a month.

Kiplinger

Biden’s Reelection May Be at Risk: The Kiplinger Letter

Biden's weakness in polls and potential impeachment may mean darker days ahead for the Dems.

Kiplinger

More Signs of Belt-Tightening and a Slowing Economy: The Kiplinger Letter

Although fewer banks are tightening lending standards, more businesses and households are feeling the squeeze.

Kiplinger

Small Businesses Hit Extra Hard by Rising Interest Rates: The Kiplinger Letter

On average, small business owners are paying interest rates in the range of 9.1%, per the NFIB.

Kiplinger

Increasingly, Red States Embrace Marijuana: The Kiplinger Letter

Ohio becomes the 24th state to legalize marijuana for recreational use via a voter referendum.

Kiplinger

The Recent Uptick In Global Trade Won’t Last: The Kiplinger Letter

Global trade continues to fall as economic growth around the world cools.

Kiplinger

Consumers Have $1 Trillion More Savings Post-Pandemic: The Kiplinger Letter

GDP data show Americans have more savings than they did pre-pandemic.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University of Michigan

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.